Predictive Technology Group highlights US patent allowance for treating patients with genetic spinal deformities, syndromes: 5 highlights

Written by Megan Wood | December 16, 2016 | Print  |

The United States Patent and Trademark Office allowed Salt Lake City-based Predictive Technology Group's patent application.

Here are five highlights:

 

1. The patent covers the administration of any "spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker."

 

2. This patent application's claims boost Predictive Technology Group's intellectual property.

 

3. This patent is additive to previous patents.

 

4. Predictive Technology Group also has other U.S. and international patent applications in the works.

 

5. The company develops and acquires proprietary technologies that address human disease and the role genes play.

 

More articles on devices:
SeaSpine, Orthofix, Amendia & more: 7 key notes
43 orthopedic, spine devices receive FDA 510(k) clearance in November 2016
Offering small orthopedic companies a competitive edge — Ortho Sales Partners' purpose

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months